Using Modeling to Project Herd Immunity: When and How We Will Get Back to Normal
As we commemorate the one-year milestone of the beginning of the COVID-19 pandemic, three major vaccine contributors are at the forefront of the vaccination efforts across the country, partnering with local and federal government officials. The objective? To reach a collective herd immunity from COVID-19 to safely return to normal. Leavitt Partners addresses the leading drivers of a timeline to herd immunity, which include vaccination administration rates, vaccine distribution, and COVID-19 specific drivers (such as mutated variant penetration in the population and current levels of immunity from prior infection).
Complete the form below to view the white paper.